KPC Pharmaceuticals (SHSE:600422) Total Equity : ¥5,712 Mil (As of Sep. 2024)

View and export this data going back to 2000. Start your Free Trial

What is KPC Pharmaceuticals Total Equity?

KPC Pharmaceuticals's total equity for the quarter that ended in Sep. 2024 was ¥5,712 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

KPC Pharmaceuticals Total Equity Historical Data

The historical data trend for KPC Pharmaceuticals's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

KPC Pharmaceuticals Total Equity Chart

KPC Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Equity

Get a 7-Day Free Trial

4,334.15

4,602.67

4,940.32

5,142.52

5,476.57

KPC Pharmaceuticals Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Equity	Get a 7-Day Free Trial															5,409.27	5,476.57	5,594.24	5,555.56	5,712.27

KPC Pharmaceuticals Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

KPC Pharmaceuticals's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2023 )	-	Total Liabilities(Q: Dec. 2023 )
	=	9565.383	-	4088.814
	=	5,477

KPC Pharmaceuticals's Total Equity for the quarter that ended in Sep. 2024 is calculated as

Total Equity	=	Total Assets(Q: Sep. 2024 )	-	Total Liabilities(Q: Sep. 2024 )
	=	10021.692	-	4309.42
	=	5,712

KPC Pharmaceuticals Total Equity Related Terms

Thank you for viewing the detailed overview of KPC Pharmaceuticals's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

KPC Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » KPC Pharmaceuticals Inc (SHSE:600422) » Definitions » Total Equity

Traded in Other Exchanges

N/A

Address

No. 166 Keyi Road, State New and High-Technology Development Zone, Kunming, Yunnan, CHN, 650106

Website

http://www.kpc.com.cn

KPC Pharmaceuticals Inc is a pharmaceutical company which focused on innovative natural botanical drugs in China. Its business scope covers traditional Chinese medicine, chemical medicine, and medicinal circulation. Its products include Panax notoginseng, gastrodine, artemether, and special botanical drugs.

Executives

Qu Xiao Ru	senior management
Xie Bo	senior management
Meng Li	senior management
Zhong Xiang Gang	senior management
Wu Sheng Long	senior management
Liu Jun Feng	senior management
Wang Lei	senior management
Zhang Meng Xun	senior management
Hu Zhen Bo	senior management
Sun Lei	senior management
Xu Chao Neng	senior management
Wang Jun	senior management
Zhao Jian	senior management
He Qin	Director
Dai Xiao Chang	senior management

KPC Pharmaceuticals Headlines

No Headlines